Guilherme Baldo holds a degree in Pharmacy from the Federal University of Rio Grande do Sul and a doctorate in Biological Sciences: Biochemistry from the same university. Currently, he is an Associate Professor in the Department of Physiology at UFRGS, a professor in the Graduate Program in Genetics and Molecular Biology, and in the Graduate Program in Physiology at UFRGS. His work is focused on gene therapy and gene editing for rare diseases. He is a member of CTNBio and participates in the National Network of Gene Therapy Specialists (RENETA), affiliated with the National Health Surveillance Agency for the evaluation of gene therapy products in the country.